Uncategorized
FDA approves AcrySof IQ ReSTOR +2.5 multifocal toric IOL with ActiveFocus design
The FDA has approved the Alcon AcrySof IQ ReSTOR +2.5 multifocal toric IOL with ActiveFocus design, according to a press release from Novartis.Designed for patients undergoing cataract surgery to address astigmatism and presbyopia, the IOL delivers clear distance vision and a range of vision for patients who want to be less dependent on glasses, the release said.